Most GLP-1 medications like semaglutide (Ozempic, Wegovy) and liraglutide are administered by subcutaneous injection, bypassing the digestive system entirely
The 100% absorption factor is huge
Switching due to weight-loss plateau at week 4 to 8
A provider should reassess progress, side effects, hormone markers, metabolic health, and whether the peptide should be continued, adjusted, paused, or stopped
We work with you to see whats the least amount of the medication needed to support you in maintaining your best health. Who Might Consider Microdosing GLP-1s (and Who Shouldnt) GLP-1s in general are typically recommended and usually only covered by insurance for people with obesity (defined as a BMI greater than 30) as well as those with a BMI greater than 27 and one or more weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol